Real-World Experience with Tofacitinib in IBD at a Tertiary Center-Reference-Cited by-同舟云学术

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

Published:2019-02-07 Issue:7 Volume:64 Page:1945-1951
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Weisshof Roni,Aharoni Golan Maya,Sossenheimer Philip H.,El Jurdi Katia,Ollech Jacob E.,Pekow Joel,Cohen Russel D.,Sakuraba Atsushi,Dalal Sushila,Rubin David T.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/article/10.1007/s10620-019-05492-y/fulltext.html

Reference17 articles.

1. Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. Prevalence of inflammatory bowel disease among adults aged >/=18 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166–1169.

2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54 (quiz e30).

3. Cohen BL, Sachar DB. Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease. BMJ. 2017;357:j2505.

4. Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:644–659 (quiz 660).

5. Amiot A, Serrero M, Peyrin-Biroulet L, et al. One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study. Aliment Pharmacol Ther. 2017;46:310–321.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis;World Journal of Gastroenterology;2024-09-14

2. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

3. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus;Digestive and Liver Disease;2024-08

4. Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study;Annals of Medicine;2024-05-30

5. Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study;American Journal of Gastroenterology;2024-04-05